North America

Tue
30
Apr

2 marijuana stocks to watch in May

The battle for supremacy in the marijuana industry is intensifying. While Canopy Growth and Aurora Cannabis have managed to capture about 50% of the Canadian market, other pot companies are attempting to improve their positions. Some firms are successful at doing so, and others, not so much. Let’s look at two marijuana companies to watch this coming May: Hexo (TSX:HEXO) and Cronos Group (TSX:CRON)(NASDAQ:CRON). One of these firms is currently flying high, and the other recently posted disappointing financial results.

Tue
30
Apr

Science: How marijuana works to help those with multiple sclerosis

Multiple sclerosis (MS) is a neurological disease in which the immune system attacks the fatty protein that protects nerve cells. The exposed and damaged (i.e. “sclerotic”) nerves lose their ability to transmit signals, and this results in a wide array of bad results, including numbness, dizziness, itching and blurred vision. More than half of people who suffer from MS experience pain, muscle stiffness or spasticity, and cognitive impairment.

It’s those last three symptoms that have been most studied in relation to medical marijuana.

Tue
30
Apr

When IoT meets the cannabis industry

Indisputably, the internet has changed the world and the way we do everything – from running our businesses to how we handle day to day tasks.

The possibility of exchanging data on such a large scale has revolutionized countless industries and transformed society into the most fast-paced technological environment that has ever existed. That said, it’s no surprise that the booming cannabis industry has its own version of technology emerging: “cannatech.” This industry is rife with cutting-edge technologies that impact aspects like agriculture, medicine, and retail. Let’s take a look at some of the most interesting applications of IoT in the cannabis industry.

Tue
30
Apr

If marijuana remains a Schedule I substance, we can never do the research everyone knows we need

Cannabis has been known to humans for thousands of years, and there is nearly universal support for medical cannabis: Over 90 percent of Americans believe that cannabis should be legalized for medical use, according to a Quinnipiac Poll. Currently, 33 states and Washington, D.C., have legalized cannabis for medical purposes, and states such as Georgia have acted to expand medical cannabis laws.

Mon
29
Apr

How recreational marijuana might affect workplace

As of today, 10 states and Washington, D.C., have legalized marijuana for recreational use for adults over 21, while 33 states have legalized medical marijuana.

Pennsylvania legalized the use of medical marijuana three years ago, and two Pennsylvania senators introduced a bill in March to permit recreational marijuana.

As discussions about recreational marijuana continue, employers are wondering how the proposal will affect workplaces across Pennsylvania.

States that have passed recreational marijuana laws strictly regulate the use of cannabis by, for example, regulating where it can be purchased and limiting how much can be grown at home.

And none of those states allow residents to use marijuana whenever or wherever they choose – including the workplace.

Mon
29
Apr

Meet the flameless device that wants to disrupt cannabis vaporizing

Back at the start of this year, the Willamette Week reported on a new type of vaporizer that would work with any pipe to make it into a vape.

Mon
29
Apr

3 high-flying pot stocks to buy

If you're considering pot stocks for your portfolio, you could be on to something. The marijuana market is worth $150 billion per year worldwide, and the potential to create new cannabis-derived products, including beverages and edibles, has beer and wine giant Constellation Brands (NYSE:STZ) thinking legal marijuana sales could eclipse $200 billion in 15 years.

Mon
29
Apr

Marijuana stocks: Breaking down the recreational-to-medical sales ratio of the top growers

Interest in the marijuana industry is heating up among investors, and for good reason. Since the year began, the very first tradable cannabis exchange-traded fund, the Horizons Marijuana Life Sciences ETF, has practically tripled the returns of the broad-based S&P 500, which is having a stellar year of its own.

Mon
29
Apr

Why Aurora Cannabis' latest technology deal matters more than you might think

For Aurora Cannabis (NYSE:ACB), 10 million Canadian dollars (roughly $7.4 million) is pretty much chump change. Sure, it's nearly one-fifth of the Canadian marijuana producer's sales last quarter. But in the grand scheme of things, it isn't a lot for Aurora to spend.

So when Aurora announced on Friday that it was investing that amount in Vancouver-based technology company EnWave (NASDAQOTH:NWVCF), the news wasn't met with major fanfare. But this deal might be more important over the long run for Aurora than you'd expect. 

Mon
29
Apr

Legal limits for cannabis-impaired driving may be impossible, THC impacts people differently

For years, states have set limits to how much alcohol drivers can have in their bloodstream. As more states legalize cannabis, they are also struggling to find similar limits and write reasonable and fair laws to determine when someone is too stoned to drive safely.

A study done by French scientists suggests it won’t happen soon.

“No legal driving limit for cannabis can catch impaired recreational users without unfairly penalizing unimpaired regular or medicinal users.”

Pages

Subscribe to RSS - North America